ProKidney develops rilparencel, a cell therapy aimed at preserving kidney function in people with chronic kidney disease and diabetes. It last closed at $1.04 on Nov 20, down 1.89% on the day. The next earnings report for PROK is expected around Wed, Mar 17, 2027, after the close. Over its last 8 reports the stock moved an average of 5.9% the session after earnings. Over the last 12 months PROK insiders bought $0 of stock on the open market and sold $1.1M, according to SEC Form 4 filings.
AI Auto Pilots
Is PROK in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold PROK.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on PROKStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
PROK · as of the Nov 20 close · updated each morning
Downtrend, nearing oversold
The stock is 13% below its 20 day and 39% below its 50 day average. It is 68% below its 200 day average, so the longer trend is down. Momentum is fading (RSI 36), near oversold. The nearest support is the Pivot S1 at $1.02, and the nearest resistance the Pivot at $1.05.
Short trendBearish
Long trendBearish
MomentumFading
StretchNear oversold
VolatilityHigh, 11.1%/day
Key levels
$2.6552 week high+154.8%
$1.74200 day average+67.3%
$1.56100 day average+50.0%
$1.4550 day average+39.4%
$1.27Swing high (Nov 9)+22.1%
$1.1820 day average+13.5%
$1.07Pivot R1+2.9%
$1.05Pivot+1.0%
$1.04Last close
$1.02Pivot S1−1.9%
$1.01Swing low (Nov 16)−2.9%
$0.8752 week low−16.3%
Indicators
RSI (14)
36.02
Weak, oversold below 30
Neutral
MACD
-0.12
Below its signal line
Bearish
Stochastic
27.7
Middle of its range
Neutral
ADX (14)
27.6
Trending down
Williams %R
-85.2
Oversold below −80, overbought above −20
Oversold
CCI (20)
-67.6
Oversold below −100, overbought above 100
Neutral
Rate of change
−8.8%
Change over 10 sessions
Bearish
ATR (14)
$0.11
Typical daily range, 11.1% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Downtrend, nearing oversold
Short trendBearish
Long trendBearish
MomentumWeak
StretchNear oversold
VolatilityNormal, 28.2%/day
Key levels
$2.6552 week high+154.8%
$1.74200 day average+67.3%
$1.56100 day average+50.0%
$1.4550 day average+39.4%
$1.27Swing high (Nov 9)+22.1%
$1.1820 day average+13.5%
$1.07Pivot R1+2.9%
$1.05Pivot+1.0%
$1.04Last close
$1.02Pivot S1−1.9%
$1.01Swing low (Nov 16)−2.9%
$0.8752 week low−16.3%
Indicators
RSI (14)
36.21
Weak, oversold below 30
Neutral
MACD
-0.19
Below its signal line
Bearish
Stochastic
16.8
Near the bottom of its range
Oversold
ADX (14)
14.1
No clear trend
Williams %R
-86.1
Oversold below −80, overbought above −20
Oversold
CCI (20)
-165.3
Oversold below −100, overbought above 100
Oversold
Rate of change
−42.2%
Change over 10 sessions
Bearish
ATR (14)
$0.29
Typical daily range, 28.1% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for PROK
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how PROK did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow PROK usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for PROKHow many large options trades hit PROK, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in PROK in the last 90 days.
From SEC Form 4 filings by PROK's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether PROK is in one of them and how their past PROK trades turned out.
ProKidney is a biotechnology company developing rilparencel, a cell therapy meant to preserve kidney function in patients with chronic kidney disease and type 2 diabetes. The treatment is made from a patient's own kidney cells, which are collected from a small kidney biopsy, processed at the company's facility, and then injected back into the kidneys. The company is based in Winston-Salem, North Carolina, and its product is still in clinical development.